Nobody is choosing between these two. The sellers here sell them together: 2 of the 19 priced listings buy both on one line, and not one figure here buys the ipamorelin half on its own. They work through two different receptors, and only one of them has an approved product behind it.
Where to buy either
ElitePhysiqMD
$274.50 per month
Longevixx
$299 per month
Oak Longevity
Publishes no figure for these on its own page. The record says what was looked at and when.
Youth & Soul
$149 per month
3 of the 14 sellers whose pages here list Tesamorelin; 3 list Ipamorelin. The overlap is not a coincidence of stock: the listings that carry Ipamorelin carry it inside something, and 2 of them name Tesamorelin as the other half.
Each of those figures is a price for the pair, not for either molecule inside it, which is why ipamorelin has no cost row at all on this site while appearing on 3 menus. The molecule that is never sold alone is the subject of can you buy ipamorelin on its own?
This is the sharpest thing these records say about what a pairing costs, and it was found by comparing figures rather than by reading them. 1 of the 14 sellers here prints the same figure for a listing that buys one of these molecules and for a listing that buys both.
ElitePhysiqMD lists “Tesamorelin” at $274.50 per month — dose not stated, and “Tesamorelin / Ipamorelin” at $274.50 per month — dose not stated. Both were read September 2026.
The mechanism row is why these two get bundled rather than ranked. Tesamorelin is recorded here as a GHRH analog and Ipamorelin as a ghrelin mimetic, and the paper that introduced the second one settled which receptor it works through by running it against antagonists of both.
A pharmacological profiling using GHRP and growth hormone-releasing hormone (GHRH) antagonists clearly demonstrated that ipamorelin, like GHRP-6, stimulates GH release via a GHRP-like receptor.
Two doors rather than one. That is the whole of the pharmacological case for pairing them, and it is also the reason a comparison between them is a slightly odd thing to ask for: the listings above are not offering a reader a choice between these two, they are offering both. What separates the two receptor classes across all 5 molecules on this site is GHRH analogs vs ghrelin mimetics; the selectivity claim that gets made about the second one, and the species it was measured in, is does ipamorelin raise cortisol? The first one’s own label, and the one use it is approved for, are read on what is tesamorelin.
Their two records sit at opposite ends of what this site can show a reader, and the contrast is the kind of thing a table hides. Ipamorelin’s comes out of a published pharmacokinetic trial in people, and the paper says what it measured and in whom.
A trial was conducted with a dose escalation design comprising 5 different infusion rates (4.21, 14.02, 42.13, 84.27 and 140.45 nmol/kg over 15 minutes) with eight healthy male subjects at each dose level.
The PK parameters showed dose-proportionality, with a short terminal half-life of 2 hours
One figure, not a span — which is why the axis below draws it as a tick rather than a bar. A single measured value is recorded as a single value here; widening it into a comfortable-looking range would print a precision the trial never offered, in the opposite direction from the midpoint collapse this site fails its own build over.
Tesamorelin’s figure comes from a product label rather than a journal, and the label is specific about whose minutes they are: 8 min in healthy subjects, one 1.4 mg dose of EGRIFTA SV. The newer formulation’s label reports 11 minutes in healthy subjects after single dose subcutaneous administration of the 1.28 mg of EGRIFTA WR.
So the difference between them is a factor of 15 to 15, and it is the whole practical difference between these two: a drug measured in minutes and a drug measured in hours, both injected daily.
Attributes down, molecules across, both columns kept at every screen width. A cell reading “not recorded” means nothing has been published either way, which is not the same as a finding of no effect. The two rows that separate this pair most are the two a price list has no column for: what receptor each reaches, and how long each lasts.
| Attribute | TesamorelinTES | IpamorelinIPA |
|---|---|---|
| Mechanism | GHRH analog 1 | ghrelin mimetic 4 |
| Half-life | 8 min 2EGRIFTA WR label: “11 minutes in healthy subjects after single dose subcutaneous administration of the 1.28 mg of EGRIFTA WR” EGRIFTA WR label, revised 03/2025 | ~2 hours 5 |
| Cortisol / prolactin | not recorded | no cortisol or prolactin rise in conscious swine 6In humans: “comparatively minimal activation of other pituitary–adrenal axes in available human studies” Dominikowski et al. 2026 |
| FDA status | approved (Egrifta SV) 2 | no approval for these uses 1 |
| Reported use | 2 mg once daily 1 | 200–300 µg, 2 or 3 injections a day, often with CJC-1295 (no DAC) 1 |
| What sellers publish | 2 figures read1 standing rate, 1 floor — quoted against 1 billing cycle. 0 of the 2 say what dose the money buys. A floor is where the pricing starts, not what anyone pays. Not a range, because these are not the same measurement. | no figure buys it on its own5 listings in these records include it, each one alongside at least one other molecule. |
The reported-use row is what people describe doing online, collected in a peer-reviewed review that labels its own table “anthropological/behavioural data, not clinical recommendations”. It is not prescribing information, and it is not what any seller here charges for.
Every figure here that touches either molecule, with the qualifier that makes it mean something. 2 of the 7 of them buy one of these two on its own; 5 buy more than one thing and are therefore not a cost for any single molecule inside them. That exclusion is computed, and counted here rather than left out quietly.
0 of the 2 drawn figures state what dose the money buys, against 1 different billing cycle and 2 different kinds of figure. Nothing here names a cheapest, and the board is in record order rather than sorted by size: a floor and a standing rate are not two sizes of one measurement.
The board scrolls sideways; the seller column and the button column both stay put.
| Seller | What the figure buys | Figure, and when it was checked | What it is | Charged | Dose | Go |
|---|---|---|---|---|---|---|
| ElitePhysiqMD | Tesamorelin“Tesamorelin” | $274.50September 2026 | standing rate | per month | dose not stated | Open listing → |
| TesamorelinIpamorelin“Tesamorelin / Ipamorelin” | $274.50September 2026 | standing rate | per month | dose not stated | ||
| Ipamorelin“CJC-1295 + Ipamorelin” — also buys CJC-1295, with or without DAC not stated | $315.00September 2026 | standing rate | per month | dose not stated | ||
| Longevixx | Tesamorelin“Tesamorelin” | from $299September 2026 | floor | per month | dose not stated | Open listing → |
| Ipamorelin“CJC-1295 / Ipamorelin” — also buys CJC-1295, with or without DAC not stated | from $329September 2026 | floor | per month | dose not stated | ||
| TesamorelinIpamorelin“Tesamorelin / Ipamorelin” | from $349September 2026 | floor | per month | dose not stated | ||
| Oak Longevity | no figure we can publishthe two figures render inside the order flow, each struck through and replaced, with a promotional code shown as applied — so what is on screen is a discounted checkout price, not a standing rate anyone is quoted before starting.September 2026 | Open site → | ||||
| Youth & Soul | SermorelinIpamorelin“Growth Hormone Optimization” — also buys NAD+ sublingual tablets (250mg); Methylene Blue; IGF-1 & hormone panel blood work review; physician monitoring & dose optimization | $149September 2026 | standing rate | per month | dose not stated | Open listing → |
Read off each seller’s own page and dated in the row. Nothing here is scored or ranked, and the rows are in the order the sellers were read.
Sellers listing Tesamorelin
3 of 14
2 figures buy it on its own; 2 name it inside a pairing.
Sellers listing Ipamorelin
3 of 14
0 figures buy it on its own; 5 name it inside a pairing.
Listings here buying both of them together
2 of 7
Out of every figure on this site that touches either molecule. One of them carries the same figure as its seller's single-molecule listing.
Counted from the 14 records behind the board, every figure read off the seller’s own page and dated. The per-seller working is on the seller records.
Every pharmacological figure on this page comes from one of the documents below. The quotations are from the abstracts as the National Library of Medicine publishes them, and each is attributed to the document the cell it belongs to actually cites. Seller figures are read off the seller’s own page and carry the date they were read.
6 documents, in the order the figures above use them. The date on each is the one printed on the document.
2 of this site’s 14 seller records carry more than one of Tesamorelin, Ipamorelin — which is the only reason they are listed here rather than everyone we have read. Their figures, with every qualifier attached, are in the board above. Some sellers here pay us a commission; it does not change who is listed or what their figure says — how we earn.
Prices four listings across three of these molecules on one catalog page and states a dose on none of them. Tesamorelin alone and tesamorelin with ipamorelin carry the identical figure, which is the clearest thing on the page: adding a second molecule changes the price by nothing. The catalog also prints “Save 10% with subscription” beside the figures.
Every figure on this catalog is a floor — the page prints “from” in front of all of them — and none states a dose, so the gaps between the four are gaps between starting points, not between what anyone pays. The CJC-1295 listing is sold only as a pairing and never says which form of CJC-1295 it contains.